Prudo-Chlebosz Raymond

CIK 00016532621 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001653262

Recent Transactions

14 trades

Purchase
Akari Therapeutics Plc$AKTX
Pre-Funded Warrants to purchase ADRs
2025-12-16$0.40/sh+618,658→ 618,658 total
Purchase
Akari Therapeutics Plc$AKTX
Warrants to purchase ADRs
2025-12-16+386,661→ 386,661 total
Purchase
Akari Therapeutics Plc$AKTX
Pre-Funded Warrants to purchase ADRs
2025-12-16$0.40/sh+386,661→ 386,661 total
Purchase
Akari Therapeutics Plc$AKTX
Warrants to purchase American Depositary Shares ("ADRs")
2025-12-16+618,658→ 618,658 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2025-03-20+225,000→ 225,000 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2025-03-20+175,000→ 175,000 total
Award
Akari Therapeutics Plc$AKTX
Series A Warrants (Right to Buy)
2025-03-06$1.12/sh+446,428→ 446,428 total
Award
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-03-06$1.12/sh+446,428→ 2,484,990 total
Award
Akari Therapeutics Plc$AKTX
Series B Warrants (Right to Buy)
2025-03-06$1.12/sh+446,428→ 446,428 total
Award
Akari Therapeutics Plc$AKTX
Warrants (Right to Buy)
2024-12-02$0.00/sh+419,286,000→ 419,286,000 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-12-02$0.00/sh+419,286,000→ 4,077,124,600 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2024-06-28+10,000,000→ 10,000,000 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-05-31$0.00/sh+1,326,258,000→ 3,657,838,600 total
Award
Akari Therapeutics Plc$AKTX
Warrants (Right to Buy)
2024-05-31$0.00/sh+1,326,258,000→ 1,326,258,000 total

Companies

Akari Therapeutics Plc
Director
$AKTX

Recent Filings

Address

C/O AKARI THERAPEUTICS, PLC 22 BOSTON WHARF ROAD FL 7

BOSTON, MA, 02210

View on SEC.gov